Aslan Fred
CIK 0001909362
President and CEODirector
Filings
9
Latest May 19, 2026
Issuers covered
1
Showing
9 of 9
Page 1
Track record
4 of 5 open-market trades scored (80% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 4 | 75% | +14.3% | +19.3% | +41.6% | -23.1% |
| 90 days | 4 | 50% | -3.2% | -7.6% | +25.8% | -23.3% |
| 180 days | 3 | 0% | -84.7% | -51.4% | -40.0% | -162.7% |
| 365 days | - | - | - | - | - | - |
Issuers
Companies where Aslan Fred has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ARTV | Artiva Biotherapeutics, Inc. | 9 | May 19, 2026 |
All filings
9 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|